- AMAG Pharmaceuticals Inc.
- Takeda Pharmaceutical Co. Ltd.
- Daiichi Sankyo Co. Ltd.
- American Reagent Inc.
- Allergan PLC
- Pharmacosmos AS
- Rockwell Medical Inc.
- Fresenius Medical Care AG & Co. KGaA
- DaVita HealthCare Partners Inc.
- Amgen Inc.
- Johnson & Johnson
- Anthem Inc.
- Aetna Inc.
- Cigna Corp.
- Kaiser Permanente
- NitroMed Inc.
- Affymax Inc.
- Takeda pays $60mm up front for rights to AMAG's Feraheme; rights returned
- Fresenius gets US rights to Luitpold's IV iron products
- NitroMed plans reverse merger with Archemix; terminated
- Deerfield wins sweetened bid to acquire NitroMed
- Takeda, Affymax expand Hematide deal; collaboration terminated
- Takeda licenses Affymax's Hematide for Japan; deal ends
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. email@example.com.
All fields are required.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.